中关村：下属公司北京华素撤回氨酚羟考酮片药品上市许可注册申请

Core Viewpoint - The company Zhongguancun announced the withdrawal of its drug registration application for Acetaminophen and Oxycodone Tablets to further improve the submission materials, indicating that this is not the end of the project and that a resubmission will occur after necessary research is completed [2] Group 1 - The company Beijing Huasu, a subsidiary of Zhongguancun, received a notice from the National Medical Products Administration regarding the termination of the drug registration application for Acetaminophen and Oxycodone Tablets [2] - The total investment in the Acetaminophen and Oxycodone Tablets project amounts to 8.861 million yuan [2] - The withdrawal of the application will not impact the company's current financial status or operating performance [2]